Sentinel Trust Co. LBA Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Sentinel Trust Co. LBA lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,951 shares of the healthcare conglomerate’s stock after purchasing an additional 261 shares during the quarter. Sentinel Trust Co. LBA’s holdings in UnitedHealth Group were worth $3,010,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the third quarter worth $37,000. DecisionPoint Financial LLC boosted its stake in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the period. Highline Wealth Partners LLC bought a new position in UnitedHealth Group in the 3rd quarter worth about $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $57,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. KeyCorp restated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Up 1.2 %

Shares of NYSE:UNH opened at $469.11 on Friday. The company has a market cap of $431.71 billion, a PE ratio of 30.26, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock’s 50-day moving average is $517.10 and its 200 day moving average is $557.79. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.83 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.79%. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.